Ra Capital Management, L.P. Protara Therapeutics, Inc. Transaction History
Ra Capital Management, L.P.
- $4.82 Billion
- Q1 2025
A detailed history of Ra Capital Management, L.P. transactions in Protara Therapeutics, Inc. stock. As of the latest transaction made, Ra Capital Management, L.P. holds 3,400,000 shares of TARA stock, worth $10.6 Million. This represents 0.3% of its overall portfolio holdings.
Number of Shares
3,400,000
Previous 3,400,000
-0.0%
Holding current value
$10.6 Million
Previous $17.9 Million
18.86%
% of portfolio
0.3%
Previous 0.29%
Shares
2 transactions
Others Institutions Holding TARA
# of Institutions
70Shares Held
29.1MCall Options Held
365KPut Options Held
108K-
Janus Henderson Group PLC London, X03.79MShares$11.9 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.8MShares$5.64 Million0.0% of portfolio
-
Blackstone Inc New York, NY1.74MShares$5.46 Million0.03% of portfolio
-
Opaleye Management Inc. Boston, MA1.73MShares$5.41 Million2.03% of portfolio
-
Velan Capital Investment Management LP Alpharetta, GA1.67MShares$5.22 Million12.25% of portfolio
About Protara Therapeutics, Inc.
- Ticker TARA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 11,267,400
- Market Cap $35.3M
- Description
- Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the identifying and advancing transformative therapies for the treatment of cancer and rare diseases. The company's lead program is TARA-002, an investigational cell therapy for the treatment of lymphatic malformations. It also develops intravenous choline chlorid...